Medtronic Spinal Cord Stimulator Lawsuit

Updated August 3, 2026. Medtronic has no spinal cord stimulator MDL and no pending centralization petition, so its cases proceed individually. It carries the highest recall count of any SCS manufacturer, concentrated in the Intellis and Vanta systems, and it is the subject of the July 2026 Schiltz order, the most consequential ruling in the tort. There is no verdict and no settlement.

Key Takeaways

No MDL and no pending petition. Medtronic is not part of MDL-3181; its cases proceed individually

Highest recall count of any SCS manufacturer: 19 recall events across 23 product records since 2020, concentrated in Intellis and Vanta

We do not claim any Medtronic SCS recall reached Class I; that is unverified. Abbott holds the only confirmed Class I SCS recall

Medtronic carries the Schiltz order (July 14, 2026), the most consequential SCS ruling to date

The Schiltz one-year filing deadline analysis makes timing urgent; there is no verdict or settlement

No MDL, no petition

Unlike Boston Scientific, which has an MDL, and Abbott and Nevro, which have pending centralization petitions, Medtronic has neither. There is no Medtronic spinal cord stimulator MDL and no pending petition to create one as of August 2026. Medtronic cases proceed individually in the district courts where they are filed. That matters procedurally: without centralization there is no single Medtronic docket, no common discovery schedule, and no bellwether program.

The recall record

Medtronic has the highest recall count of any spinal cord stimulator manufacturer, with 19 recall events across 23 product records since 2020, concentrated in the Intellis and Vanta systems. That volume is notable, but volume alone does not establish severity. We have not verified that any Medtronic spinal cord stimulator recall reached Class I, the FDA's most serious category, so we do not claim one. For comparison, Abbott holds the only confirmed Class I spinal cord stimulator recall of any manufacturer.

The Schiltz order

The most consequential spinal cord stimulator ruling to date came from Judge Patrick Schiltz in the District of Minnesota on July 14, 2026. He rejected the theory that manufacturers abused the premarket-approval supplement process to introduce significantly modified devices without fresh clinical evaluation, noting that plaintiffs cited no statutory or regulatory language describing when a new premarket approval, rather than a supplement, is required. He then dismissed three of four plaintiffs as time-barred under one-year state limitations periods in Kentucky and Tennessee. Critically, he held the clock starts on inquiry notice, which he located at the earlier of being advised to turn the device off or the onset of dramatic new symptoms after implant. None of those plaintiffs had an explant, and revision or explant surgery was not treated as the trigger.

The practical takeaway is the filing deadline. The two-to-four-year windows advertised on many firm pages may be wrong for spinal cord stimulator claims. Deadlines vary by state and the Schiltz analysis will not apply everywhere, but treat the timeline as urgent and confirm the deadline that applies to you with a licensed attorney.

Devices and status

Medtronic spinal cord stimulator devices reported in the litigation include the Intellis, Vanta, Inceptiv, and Restore systems. There is no verdict and no settlement in spinal cord stimulator litigation against Medtronic or any other manufacturer, and we do not publish projected per-case figures because no verified source has published any.

Frequently Asked Questions

Is there a Medtronic spinal cord stimulator MDL?

No. Medtronic has no spinal cord stimulator MDL and no pending centralization petition as of August 2026. It is not part of MDL-3181, which covers Boston Scientific only. Medtronic spinal cord stimulator cases proceed individually in the courts where they are filed.

What is Medtronic’s spinal cord stimulator recall history?

Medtronic has the highest recall count of any spinal cord stimulator manufacturer, with 19 recall events across 23 product records since 2020, concentrated in the Intellis and Vanta systems. We have not verified that any Medtronic spinal cord stimulator recall reached Class I, the FDA’s most serious category, so we do not claim one. By contrast, Abbott holds the only confirmed Class I spinal cord stimulator recall.

What is the Schiltz order and why does it matter?

In a July 14, 2026 order in the District of Minnesota, Judge Patrick Schiltz issued the most consequential spinal cord stimulator decision to date. He rejected the theory that manufacturers abused the premarket-approval supplement process, noting plaintiffs cited no statutory or regulatory language describing when a new premarket approval rather than a supplement is required. He also dismissed three of four plaintiffs as time-barred under one-year state limitations periods, holding the clock starts on inquiry notice at the earlier of being advised to turn the device off or the onset of dramatic new symptoms, not at explant.

Have there been any Medtronic spinal cord stimulator settlements or verdicts?

No. There has never been a jury verdict or a settlement against Medtronic in spinal cord stimulator product liability litigation. Any specific settlement figure circulating online is a projection with no verifiable source, and we do not publish such figures.